Prevalence and underdiagnosis of chronic obstructive pulmonary disease among patients at risk in primary care
暂无分享,去创建一个
Gordon H. Guyatt | Richard Hodder | Kylie Hill | Roger S. Goldstein | G. Guyatt | M. Stanbrook | R. Goldstein | K. Hill | D. Heels-Ansdell | W. Tan | R. Hodder | Wan C. Tan | Matthew B. Stanbrook | Maria Blouin | Lori L. Davis | Diane M. Heels-Ansdell | Marko Erak | Pauline J. Bragaglia | Itamar E. Tamari | M. Erak | Maria Blouin | I. Tamari | Lori Davis | Pauline Bragaglia
[1] P. Jones,et al. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease , 1999, Thorax.
[2] N. Choudry,et al. Early Detection and Impaired Quality of Life in COPD GOLD Stage 0: A Pilot Study , 2007, COPD.
[3] J. Bourbeau,et al. Promoting effective self-management programmes to improve COPD , 2009, European Respiratory Journal.
[4] T. Greenhalgh,et al. Effect on smoking quit rate of telling patients their lung age: the Step2quit randomised controlled trial , 2008, BMJ : British Medical Journal.
[5] D. Mannino,et al. International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study , 2007, The Lancet.
[6] L. Davies,et al. Effect of primary-care spirometry on the diagnosis and management of COPD , 2006, European Respiratory Journal.
[7] D. Górecka,et al. Smokers with airway obstruction are more likely to quit smoking , 2006, Thorax.
[8] F. Maltais,et al. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease--2003. , 2003, Canadian respiratory journal.
[9] P. Barnes,et al. Chronic obstructive pulmonary disease. , 2000, The New England journal of medicine.
[10] Victor A Kiri,et al. Chronic obstructive pulmonary disease and hospitalizations for pneumonia in a US cohort. , 2009, Respiratory medicine.
[11] A. Menezes,et al. Spirometry quality-control strategies in a multinational study of the prevalence of chronic obstructive pulmonary disease. , 2008, Respiratory care.
[12] Shengming Liu,et al. Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey. , 2007, American journal of respiratory and critical care medicine.
[13] F. Rengo,et al. Do GOLD stages of COPD severity really correspond to differences in health status? , 2003, European Respiratory Journal.
[14] P. Jakobsson,et al. The impact of repeated spirometry and smoking cessation advice on smokers with mild COPD , 2006, Scandinavian journal of primary health care.
[15] D. Mannino,et al. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD , 2008, European Respiratory Journal.
[16] A. Gulsvik,et al. Post-bronchodilator spirometry reference values in adults and implications for disease management. , 2006, American journal of respiratory and critical care medicine.
[17] J Stocks,et al. Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction , 2008, Thorax.
[18] angesichts der Corona-Pandemie,et al. UPDATE , 1973, The Lancet.
[19] K. R. Chapman,et al. Epidemiology and costs of chronic obstructive pulmonary disease , 2006, European Respiratory Journal.
[20] A. Buist. Guidelines for the management of chronic obstructive pulmonary disease. , 2002, Respiratory medicine.
[21] Cesar G Victora,et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study , 2005, The Lancet.
[22] D. Mannino,et al. Global Initiative on Obstructive Lung Disease (GOLD) classification of lung disease and mortality: findings from the Atherosclerosis Risk in Communities (ARIC) study. , 2006, Respiratory medicine.
[23] Sean Keenan,et al. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 update. , 2007, Canadian respiratory journal.
[24] BTS guidelines for the management of chronic obstructive pulmonary disease. The COPD Guidelines Group of the Standards of Care Committee of the BTS. , 1997, Thorax.
[25] S. Aaron,et al. Spirometry in the primary care setting: influence on clinical diagnosis and management of airflow obstruction. , 2006, Chest.
[26] Chronic obstructive pulmonary disease. National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care. , 2004, Thorax.
[27] J L Hankinson,et al. Spirometric reference values from a sample of the general U.S. population. , 1999, American journal of respiratory and critical care medicine.
[28] J. Hankinson,et al. Standardisation of spirometry , 2005, European Respiratory Journal.
[29] C. van Weel,et al. Current clinical guideline definitions of airflow obstruction and COPD overdiagnosis in primary care , 2008, European Respiratory Journal.
[30] R. West,et al. Prevalence, diagnosis and relation to tobacco dependence of chronic obstructive pulmonary disease in a nationally representative population sample , 2006, Thorax.
[31] K. Wood,et al. FEV1/FVC ratio of 70% misclassifies patients with obstruction at the extremes of age. , 2006, Chest.
[32] R. Peto,et al. The natural history of chronic airflow obstruction. , 1977, British medical journal.
[33] J. Zieliński,et al. Early detection of COPD in a high-risk population using spirometric screening. , 2001, Chest.
[34] T L Petty,et al. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. , 2000, Archives of internal medicine.
[35] D. Forman,et al. Delays in managing lung cancer. , 2004, Thorax.
[36] Alan D. Lopez,et al. Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study , 1997, The Lancet.